arabinofuranosyluracil has been researched along with Aging in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crome, P; Holdich, TA; Peck, RW; Posner, J; Weatherley, BC; Wootton, R | 1 |
| Capizzi, RL; Cheng, E; Cheng, YC; Kute, T; Rathmell, JP; White, JC; Yang, JL | 1 |
1 review(s) available for arabinofuranosyluracil and Aging
| Article | Year |
|---|---|
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation.
Topics: Aging; Animals; Arabinofuranosyluracil; Biological Transport; Bone Marrow; Cell Line; Cell Membrane; Clinical Trials as Topic; Cytarabine; DNA; Dose-Response Relationship, Drug; Drug Resistance; Half-Life; Humans; Interphase; Leukemia; Leukemia L5178; Time Factors | 1985 |
2 trial(s) available for arabinofuranosyluracil and Aging
| Article | Year |
|---|---|
Pharmacokinetics and tolerability of single oral doses of 882C87, a potent, new anti-varicella-zoster virus agent, in healthy volunteers.
Topics: Administration, Oral; Adult; Aged; Aging; Antiviral Agents; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Fasting; Herpesvirus 3, Human; Humans; Male; Single-Blind Method | 1995 |
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation.
Topics: Aging; Animals; Arabinofuranosyluracil; Biological Transport; Bone Marrow; Cell Line; Cell Membrane; Clinical Trials as Topic; Cytarabine; DNA; Dose-Response Relationship, Drug; Drug Resistance; Half-Life; Humans; Interphase; Leukemia; Leukemia L5178; Time Factors | 1985 |